Exploration of Patient Self-medication Practices During and After Cancer in France (CASEME)

May 3, 2022 updated by: University Hospital, Clermont-Ferrand

Exploration of Patient Self-medication Practices During and After Cancer in France: Cross-sectional Observational Study With Online Response

The purpose of this study is to assess the patient self-medication practices during and after cancer in France, using an online questionnaire

Study Overview

Status

Completed

Conditions

Detailed Description

Patients will be contacted by email from patient's associations. Patients will be informed of the objectives of the study and will be free to answer or not to the online questionnaire.

Study Type

Observational

Enrollment (Actual)

681

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Clermont-Ferrand, France
        • Chu Clermont-Ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients contacted by cancer patient's association

Description

Inclusion Criteria:

  • Past or active cancer

Exclusion Criteria:

  • Speaking French
  • Not living in France

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-medication
Time Frame: day 1
declaration of a practice of self-medication
day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Class of products used in self-medication
Time Frame: day 1
non-prescription medicine, herbal medicine, aromatherapy, homeopathy, and food supplements
day 1
Indication for self-medication
Time Frame: day 1
For treatment of side-effects, improvements in anti-cancer effects
day 1
Origin of self-medication products
Time Frame: day 1
pharmacy, market, internet, other
day 1
Perception of adverse effects and drug-drug interaction related to self medication
Time Frame: day 1
yes / no
day 1
QLQ-C30 questionnaire
Time Frame: day 1
Global health status Functional scales Physical functioning Role functioning Emotional functioning Cognitive functioning Social functioning Fatigue Nausea and vomiting Pain Dyspnoea Insomnia Appetite loss Constipation Diarrhoea Financial difficulties
day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Clermont-Ferrand

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 14, 2021

Primary Completion (Actual)

April 30, 2022

Study Completion (Actual)

April 30, 2022

Study Registration Dates

First Submitted

December 1, 2021

First Submitted That Met QC Criteria

December 1, 2021

First Posted (Actual)

December 14, 2021

Study Record Updates

Last Update Posted (Actual)

May 4, 2022

Last Update Submitted That Met QC Criteria

May 3, 2022

Last Verified

December 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • RNI 2021 BALAYSSAC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe